To include your compound in the COVID-19 Resource Center, submit it here.

Poniard cancer news

Poniard disclosed in its 1Q11 earnings that it will require additional capital to continue operations

Read the full 151 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE